<?xml version="1.0" encoding="UTF-8" standalone="yes"?><?xml-stylesheet type="text/xsl" href="/oai-pmh-repository/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2026-10-14T05:26:45Z</responseDate>
    <request verb="GetRecord" identifier="oai:data.mendeley.com/6z6zd9gjbb.1" metadataPrefix="oai_dc">https://data.mendeley.com/oai</request>
    <GetRecord>
        <record>
            <header>
                <identifier>oai:data.mendeley.com/6z6zd9gjbb.1</identifier>
                <datestamp>2021-10-05T06:47:30Z</datestamp>
            </header>
            <metadata><oai_dc:dc xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <dc:creator>Tong, Yuquan</dc:creator>
    <dc:title>RNA-seq data for a small molecule alleviating C9orf72 ALS pathology by interfacing G4C2 RNA repeats with endogenous decay pathways</dc:title>
    <dc:publisher>Mendeley Data</dc:publisher>
    <dc:description>A hexanucleotide repeat expansion in intron 1 of the C9orf72 gene is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia, or c9ALS/FTD.  The RNA transcribed from the expansion, r(G4C2)exp, causes various disease-associated pathologies, including intron retention, aberrant translation that produces toxic dipeptide repeat proteins (DPRs), and sequestration of RNA-binding proteins (RBPs) within RNA foci in a subset of cells in the central nervous system.  Identification of this RNA species as the central toxin in c9ALS/FTD has provided a potential therapeutic target.  Here, we show a repurposed antitumor drug obtained through compound derivatization potently and selectively interacts with the disease-associated r(G4C2)exp and mitigates c9ALS/FTD disease pathologies in patient-derived spinal neurons. We performed the total RNA-seq of compound-treated cells from both ALS-patients and healthy donors to support that this small molecule has limited off targets on the human transcriptome.</dc:description>
    <dc:subject>RNA Sequencing</dc:subject>
    <dc:contributor>Bush, Jessica</dc:contributor>
    <dc:contributor>Meyer, Samantha</dc:contributor>
    <dc:contributor>Aikawa, Haruo</dc:contributor>
    <dc:contributor>Childs-Disney, Jessica</dc:contributor>
    <dc:contributor>Disney, Matthew</dc:contributor>
    <dc:type>Dataset</dc:type>
    <dc:identifier>doi:10.17632/6z6zd9gjbb.1</dc:identifier>
    <dc:identifier>oai:data.mendeley.com/6z6zd9gjbb.1</dc:identifier>
    <dc:rights>Creative Commons Attribution 4.0 International</dc:rights>
    <dc:rights>http://creativecommons.org/licenses/by/4.0</dc:rights>
    <dc:relation>https://data.mendeley.com/datasets/6z6zd9gjbb</dc:relation>
    <dc:date>2021-10-05T06:47:30Z</dc:date>
</oai_dc:dc></metadata>
        </record>
    </GetRecord>
</OAI-PMH>
